NCT04426643View on ClinicalTrials.gov

Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

February 20, 2021

Study Completion Date

March 31, 2021

Conditions
Urinary Incontinence
Interventions
BIOLOGICAL

Autologous adipose-derived mesenchymal stem cells

Autologous adipose-derived mesenchymal stem cells mixed with collagen solution injected in submucosal space

OTHER

Standard treatment according to the Clinical protocols

Standard treatment according to the Clinical protocols

Trial Locations (1)

220072

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk

All Listed Sponsors
collaborator

N.N. Alexandrov National Cancer Centre

OTHER_GOV

lead

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

OTHER_GOV

NCT04426643 - Treatment of Urinary Incontinence in Men After Prostatectomy With Autologous Adipose-derived Mesenchymal Stem Cells | Biotech Hunter | Biotech Hunter